Clinical Trial Update: IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pomalidomide in combination with dexamethasone for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: University Hospital, Lille | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED